These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21925428)

  • 1. Lessons learned from clinical trials in acute heart failure: phase 3 drug trials.
    O'Connor CM; Fiuzat M
    Heart Fail Clin; 2011 Oct; 7(4):451-6. PubMed ID: 21925428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of phase II acute heart failure syndromes clinical trials.
    Pang PS; Gheorghiade M
    Heart Fail Clin; 2011 Oct; 7(4):441-50. PubMed ID: 21925427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the enoximone clinical trials program.
    Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
    J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding pieces of the puzzle of nonresponse to cardiac resynchronization therapy.
    Gorcsan J
    Circulation; 2011 Jan; 123(1):10-2. PubMed ID: 21173347
    [No Abstract]   [Full Text] [Related]  

  • 5. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the management of chronic heart failure.
    Haddad H; Mielniczuk L; Davies RA
    Curr Opin Cardiol; 2012 Mar; 27(2):161-8. PubMed ID: 22233978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in the elderly: a realistic option for an increasing population?
    António N; Elvas L; Gonçalves L; Providência LA
    Int J Cardiol; 2012 Feb; 155(1):49-51. PubMed ID: 21334076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsurgical therapy for heart failure.
    Park KW
    Int Anesthesiol Clin; 2012; 50(3):1-21. PubMed ID: 22735717
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of end-stage heart failure.
    Murthy S; Lipman HI
    Prim Care; 2011 Jun; 38(2):265-76, viii. PubMed ID: 21628038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure.
    Zaręba W
    Cardiol J; 2010; 17(6):543-8. PubMed ID: 21154255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Almanac 2011: heart failure. An editorial overview of selected research that has driven recent advances in clinical cardiology].
    Clark AL
    G Ital Cardiol (Rome); 2011 Dec; 12(12):787-95. PubMed ID: 22158449
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiac resynchronization therapy: a review of clinical trials and criteria for identifying the appropriate patient.
    Abraham WT
    Rev Cardiovasc Med; 2003; 4 Suppl 2():S30-7. PubMed ID: 12776011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Year in Cardiology 2012: heart failure.
    McDonagh TA
    Eur Heart J; 2013 Feb; 34(7):499-502. PubMed ID: 23321348
    [No Abstract]   [Full Text] [Related]  

  • 14. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ].
    Przybylski A
    Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes.
    Tamargo J; Rosano GM; Delpón E; Ruilope L; López-Sendón J
    Int J Cardiol; 2017 Apr; 233():1-11. PubMed ID: 28161130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome.
    Boriani G; Rapezzi C; Diemberger I; Gonzini L; Gorini M; Lucci D; Sinagra G; Cooke RM; Di Pasquale G; Tavazzi L; Maggioni AP
    J Eval Clin Pract; 2010 Feb; 16(1):82-91. PubMed ID: 19874436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Vulnerable Phase of Heart Failure.
    Gracia E; Singh P; Collins S; Chioncel O; Pang P; Butler J
    Am J Ther; 2018; 25(4):e456-e464. PubMed ID: 29985824
    [No Abstract]   [Full Text] [Related]  

  • 18. Interventional electrophysiology and cardiac resynchronization therapy: delivering electrical therapies for heart failure.
    Burkhardt JD; Wilkoff BL
    Circulation; 2007 Apr; 115(16):2208-20. PubMed ID: 17452619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
    Gheorghiade M; Adams KF; Cleland JG; Cotter G; Felker GM; Filippatos GS; Fonarow GC; Greenberg BH; Hernandez AF; Khan S; Komajda M; Konstam MA; Liu PP; Maggioni AP; Massie BM; McMurray JJ; Mehra M; Metra M; O'Connell J; O'Connor CM; Pang PS; Piña IL; Sabbah HN; Teerlink JR; Udelson JE; Yancy CW; Zannad F; Stockbridge N;
    Am Heart J; 2009 Jun; 157(6):957-70. PubMed ID: 19464405
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac contractility modulation: the next cardiac resynchronization therapy or another renal sympathetic denervation?
    Mentz RJ; Butler J
    J Card Fail; 2015 Jan; 21(1):24-6. PubMed ID: 25463742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.